Richard A. Morgan
Director/Board Member at American Society of Gene & Cell Therapy
Profile
Richard A.
Morgan is currently the Director at the American Society of Gene & Cell Therapy.
Prior to this, he was the Senior Vice President-Immunogenetics at Editas Medicine, Inc. from 2018 to 2021.
He received his undergraduate degree from Brandeis University and his doctorate from The Johns Hopkins University.
Richard A. Morgan active positions
| Companies | Position | Start |
|---|---|---|
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Director/Board Member | - |
Former positions of Richard A. Morgan
| Companies | Position | End |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 31/01/2021 |
Training of Richard A. Morgan
| The Johns Hopkins University | Doctorate Degree |
| Brandeis University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EDITAS MEDICINE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
- Stock Market
- Insiders
- Richard A. Morgan
